Q: What can you tell me about Revive Therapeutics. I know it's risky and you likely won't recommend it, but any information would be helpful. The stock has jumped on news of receiving orphan drug status for one of their programs. Is this overly significant? I know it creates excitement, but ultimately how does it add to the actual value of the stock?
Q: Hi. I hold a position of INVESCO S&P S/C HLTH CARE ETF in my portfolio. It's a diversified (75 stocks) US small cap healthcare ETF.
I would like your opinion please. Thank you.
Q: Hi team, I would like to add some US health care (which I know you don't cover) to my non-registered account for a long term hold and was wondering which one you like better between SYK and ISRG. I am ok with some risk.
Thanks
Q: Hello, I am looking to add IHI to the healthcare allocation of my portfolio (10%) but would like to sell one existing holding first. Current healthcare related holdings are JNJ, ABBV, GUD and SIS (although I have SIS filed under Industrials). My question: which of JNJ and ABBV would you advise selling? Thank-you.
Q: I know you don't have much info. on use co. but was wondering if anyone had anything on this co. Thank for valuable information and guidance over the years.I have been a member from the start and without your guidance I would have quit the stock market.I'm 81 years old and won't quit unless you do. Cheers Jim
Q: Last week, Resverlogix received a positive confirmation from the FDA that it would likely support approval of BETon MACE based on the result of its Phase 3 study. The stock moved up ~28% today. It shows great promise in treating types of cardiovascular disease. From your experience, is it normal for the FDA to offer a positive comment? Would you have an opinion based on the FDA comment to open a position? I am a prudent investor yet have room for higher risk opportunities.
Thank you
Q: I know you like COV and it has been rocketing up. I am wary about buying in now that it's at an all time high after such tear. Should I step in today?
Q: Good evening 5i gang. Stryker has dropped with the talk about Boston Scientific purchase. Could this be a good time to purchase more. ? I have half a position. Should we expect more volitility?
Also..I just want to say thankyou. I joined in around March or April 2014. I am up 50%. That was one of the best decisions of my life.
Thank you
Q: Prometic Life Sciences has taken a beating over the last few months and I am very much under water. Is this stock worth holding on to for the next two years. Is it likely to recover
Q: Hello Folks:
My only health care stock is a 7% weighting of JNJ. I am considering adding UNH... would you think this prudent with this stock’s PE at 23%. What is your view on JNJ; would it be reasonable to fund a UNH purchase by selling some JNJ or would you use other money?
Thanks again for your “most valuable service”!